MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to CrizotinibLENNERZ, Jochen K; KWAK, Eunice L; SALGIA, Ravi et al.Journal of clinical oncology. 2011, Vol 29, Num 36, pp 4803-4810, issn 0732-183X, 8 p.Article

Crizotinib in ROS1-Rearranged Non―Small-Cell Lung CancerSHAW, Alice T; OU, Sai-Hong I; DOEBELE, Robert C et al.The New England journal of medicine. 2014, Vol 371, Num 21, pp 1963-1971, issn 0028-4793, 9 p.Article

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung CancerSOLOMON, Benjamin J; MOK, Tony; IYER, Shrividya et al.The New England journal of medicine. 2014, Vol 371, Num 23, pp 2167-2177, issn 0028-4793, 11 p.Article

Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced CancerFLAHERTY, Keith T; LORUSSO, Patricia M; DEMICHELE, Angela et al.Clinical cancer research (Print). 2012, Vol 18, Num 2, pp 568-576, issn 1078-0432, 9 p.Article

ROS1 Rearrangements Define a Unique Molecular Class of Lung CancersBERGETHON, Kristin; SHAW, Alice T; MARK, Eugene J et al.Journal of clinical oncology. 2012, Vol 30, Num 8, pp 863-870, issn 0732-183X, 8 p.Article

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral MAPK/ERK Kinase Inhibitor PD-0325901 in Patients with Advanced CancersLORUSSO, Patricia M; KRISHNAMURTHI, Smitha S; RICART, Alejandro D et al.Clinical cancer research (Print). 2010, Vol 16, Num 6, pp 1924-1937, issn 1078-0432, 14 p.Article

Acquired Resistance to Crizotinib from a Mutation in CD74―ROS1AWAD, Mark M; KATAYAMA, Ryohei; WILNER, Keith D et al.The New England journal of medicine. 2013, Vol 368, Num 25, pp 2395-2401, issn 0028-4793, 7 p.Article

Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung CancerSHAW, Alice T; KIM, Dong-Wan; WU, Yi-Long et al.The New England journal of medicine. 2013, Vol 368, Num 25, pp 2385-2394, issn 0028-4793, 10 p.Article

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphomaLEONARD, John P; LACASCE, Ann S; NEUBERG, Donna S et al.Blood. 2012, Vol 119, Num 20, pp 4597-4607, issn 0006-4971, 11 p.Article

Prediction of Oral Pharmacokinetics of cMet Kinase Inhibitors in Humans: Physiologically Based Pharmacokinetic Model Versus Traditional One-Compartment ModelYAMAZAKI, Shinji; SKAPTASON, Judith; ROMERO, David et al.Drug metabolism and disposition. 2011, Vol 39, Num 3, pp 383-393, issn 0090-9556, 11 p.Article

Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic TumorBUTRYNSKI, James E; D'ADAMO, David R; KWAK, Eunice L et al.The New England journal of medicine. 2010, Vol 363, Num 18, pp 1727-1733, issn 0028-4793, 7 p.Article

The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgeryWILNER, Keith D; ANZIANO, Richard J; JOHNSON, Arlene C et al.Journal of clinical psychopharmacology. 2002, Vol 22, Num 2, pp 206-210, issn 0271-0749Article